DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Nexavar (Sorafenib) - Reports of Side Effects & Adverse Reactions

 



This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Nexavar (Sorafenib). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.

Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.

All cases (519)
     Diarrhoea (77)Rash (66)Fatigue (55)more >>

Cases resulting in a serious event (433)
     Diarrhoea (55)Rash (52)Death (48)more >>

Cases resulting in death (99)
     Hepatic Failure (7)Fatigue (7)Renal Cell Carcinoma Stage Unspecified (7)more >>

Cases resulting in life threatening events (24)
     Cardiac Arrest (9)Palmar-Plantar Erythrodysaesthesia Syndrome (8)Neuropathy Peripheral (5)more >>

Cases resulting in hospitalization (170)
     Diarrhoea (26)Rash (24)Fatigue (23)more >>

Cases resulting in disability (37)
     Palmar-Plantar Erythrodysaesthesia Syndrome (13)Abasia (11)Pain in Extremity (6)more >>

Cases resulting in other serious reactions (235)
     Diarrhoea (39)Rash (36)Palmar-Plantar Erythrodysaesthesia Syndrome (27)more >>

Below is a sample of reports where side effects / adverse reactions may be related to Nexavar (Sorafenib). For a complete list and/or a specific selection of reports, please use the links in the index above.

Adverse event in male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: male

Adverse reactions / side effects: Blood Pressure Increased, Diarrhoea

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in 70 year old female receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 70 year old female, weighing 61.7 kg (135.7 pounds)

Adverse reactions / side effects: Pain in Extremity, Skin Exfoliation, Palmar-Plantar Erythrodysaesthesia Syndrome, Rash, Paraesthesia, Dysphonia, Diarrhoea, Sensory Disturbance, Blister

Suspect drug(s):
Nexavar
    Dosage: see image
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2006-01-10
    End date: 2006-01-23

Nexavar
    Dosage: see image
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2006-06-06
    End date: 2007-08-10

Nexavar
    Dosage: see image
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2006-01-30

Nexavar
    Dosage: see image
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2007-08-18

Other drugs received by patient: Lotrel; Lipitor; Bumex; Atenolol



Adverse event in female receiving Nexavar (Sorafenib)

Reported by a consumer/non-health professional from United States on 2007-10-31

Patient: female

Adverse reactions / side effects: Stomach Discomfort

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: male

Adverse reactions / side effects: Pain in Extremity, Palmar-Plantar Erythrodysaesthesia Syndrome, Nasal Congestion, Constipation, Throat Tightness, Diarrhoea, Mouth Breathing, Pharyngolaryngeal Pain, Gait Disturbance, Ear Congestion, Blister

Suspect drug(s):
Nexavar
    Dosage: 400 mg, bid, oral; 600 mg, total daily, oral
    Administration route: Oral
    Indication: Hepatic Neoplasm Malignant
    Start date: 2007-03-01

Nexavar
    Dosage: 400 mg, bid, oral; 600 mg, total daily, oral
    Administration route: Oral
    Indication: Metastases TO Abdominal Cavity
    Start date: 2007-03-01

Other drugs received by patient: Aspirin



Adverse event in receiving Nexavar (Sorafenib)

Reported by a physician from United States on 2007-10-31

Patient:

Adverse reactions / side effects: Diarrhoea

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in receiving Nexavar (Sorafenib)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-31

Patient:

Adverse reactions / side effects: Urticaria, Rash, Rash Maculo-Papular

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in 86 year old female receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 86 year old female

Adverse reactions / side effects: Pruritus, Alopecia, Rash Macular, Paraesthesia

Suspect drug(s):
Nexavar (Sorafenib)

Other drugs received by patient: Lisinopril; Mucinex; Benadryl



Adverse event in 56 year old male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 56 year old male

Adverse reactions / side effects: Blood Pressure Increased, Pruritus, Swelling Face, Pain in Extremity, Skin Exfoliation, Rash, Erythema, Paraesthesia, Burning Sensation

Suspect drug(s):
Nexavar
    Dosage: 40 mg bid oral ; 400 mg om oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2007-05-03
    End date: 2007-05-01

Nexavar
    Dosage: 40 mg bid oral ; 400 mg om oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2007-05-20

Other drugs received by patient: Amlodipine; Lunesta; Acetaminophen



Adverse event in 53 year old male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 53 year old male

Adverse reactions / side effects: Drug Toxicity, Burning Sensation, Localised Infection, Fatigue, Oedema Peripheral, Pyrexia, Rash, Erythema

Adverse event resulted in: hospitalization

Suspect drug(s):
Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Metastases TO Bone
    Start date: 2006-07-12
    End date: 2006-10-01

Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2006-07-12
    End date: 2006-10-01

Other drugs received by patient: Percocet; Zetia; Celebrex; Testosterone; Oscal (Calcium Carbonate)



Adverse event in male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: male

Adverse reactions / side effects: Rash

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: male

Adverse reactions / side effects: Palmar-Plantar Erythrodysaesthesia Syndrome

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in male receiving Nexavar (Sorafenib)

Reported by a physician from United States on 2007-10-31

Patient: male

Adverse reactions / side effects: Lower Gastrointestinal Haemorrhage

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in 61 year old female receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 61 year old female

Adverse reactions / side effects: Pain in Extremity, Diarrhoea, Oral Pain

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in 58 year old female receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 58 year old female, weighing 74.8 kg (164.7 pounds)

Adverse reactions / side effects: Stomatitis, Abdominal Abscess, Diarrhoea, Pneumoperitoneum, Rash, Diverticular Perforation

Adverse event resulted in: life threatening event, hospitalization

Suspect drug(s):
Nexavar
    Dosage: 400 mg, bid, oral, 200 mg, bid, oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2006-11-01
    End date: 2007-01-01

Nexavar
    Dosage: 400 mg, bid, oral, 200 mg, bid, oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2007-01-01
    End date: 2007-07-06

Other drugs received by patient: Glipizide; Avandia; Klor-CON; Mavik; Allopurinol; Zyrtec; Dolobid; Lasix; Vytorin; Centrum Silver; Toprol-XL; Imodium



Adverse event in 82 year old male receiving Nexavar (Sorafenib)

Reported by a consumer/non-health professional from United States on 2007-10-31

Patient: 82 year old male

Adverse reactions / side effects: Nausea, Rash Pruritic

Suspect drug(s):
Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Lung Neoplasm Malignant
    Start date: 2007-07-21

Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2007-07-21



Adverse event in female receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: female

Adverse reactions / side effects: Diarrhoea

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: male

Adverse reactions / side effects: Diarrhoea

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in receiving Nexavar (Sorafenib)

Reported by a physician from United States on 2007-10-31

Patient:

Adverse reactions / side effects: Blood Pressure Increased, Anaemia

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in 62 year old female receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 62 year old female, weighing 78.9 kg (173.6 pounds)

Adverse reactions / side effects: Weight Decreased, Arthralgia, Diarrhoea

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: male

Adverse reactions / side effects: Visual Disturbance

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in 76 year old male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 76 year old male

Adverse reactions / side effects: Diarrhoea, Rash

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in 62 year old male receiving Nexavar (Sorafenib)

Reported by a individual with unspecified qualification from United States on 2007-10-31

Patient: 62 year old male

Adverse reactions / side effects: Squamous Cell Carcinoma, Skin Lesion

Suspect drug(s):
Nexavar
    Dosage: 200 mg, qd, oral
    Administration route: Oral
    Indication: Metastases TO Kidney
    Start date: 2007-01-01

Nexavar
    Dosage: 200 mg, qd, oral
    Administration route: Oral
    Indication: Metastatic Renal Cell Carcinoma
    Start date: 2007-01-01



Adverse event in receiving Nexavar (Sorafenib)

Reported by a physician from United States on 2007-10-31

Patient:

Adverse reactions / side effects: Palmar-Plantar Erythrodysaesthesia Syndrome, Rash

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in receiving Nexavar (Sorafenib)

Reported by a physician from United States on 2007-10-31

Patient:

Adverse reactions / side effects: Palmar-Plantar Erythrodysaesthesia Syndrome

Suspect drug(s):
Nexavar (Sorafenib)



Adverse event in 77 year old male receiving Nexavar (Sorafenib)

Reported by a physician from United States on 2007-10-31

Patient: 77 year old male

Adverse reactions / side effects: Hypogeusia, Diarrhoea, Headache

Suspect drug(s):
Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Metastases TO Lung
    Start date: 2006-04-20
    End date: 2006-05-01

Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2006-04-20
    End date: 2006-05-01

Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Metastases TO Lung
    Start date: 2006-05-22
    End date: 2006-05-23

Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2006-05-22
    End date: 2006-05-23

Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Metastases TO Lung
    Start date: 2006-05-24

Nexavar
    Dosage: 400 mg, bid, oral
    Administration route: Oral
    Indication: Renal Cell Carcinoma Stage Unspecified
    Start date: 2006-05-24

Other drugs received by patient: Lipitor; Bisoprolol Fumarate and Hydrochlorothiazide; Calcium; MVI (Vitamins Nos); Vicodin; Imdur; Fish OIL; Prilosec; Oxycodone HCL; Senna; Colace

-- advertisement -- The American Red Cross
We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2009